Consistency Data
![](/dist/images/v10/3-2Reduction@2x.png)
- 37% and 40% reduction observed after 2 weeks of treatment in the 10-mg group
- 63% and 40% reduction observed after 2 weeks of treatment in the 5-mg group
![](/dist/images/v10/Chewable-tout-2X.png)
![](/dist/images/v10/disolvetabs_mobile@2x.png)
![](/dist/images/v10/20-JJZYR-2114-Email-A1-DABBLER.png)
![](/dist/images/v10/20-JJZYR-2114-Email-A1-DABBLER-Opt1_mobile@2x.png)
A story for caregivers to share with kids
Popular 2-part set helps families manage allergies. Available to download in English and Spanish.
*All studies are multicenter, randomized, placebo-controlled, double-blind in children ages 2 to 11 years with previous diagnosis of SAR, and adequate minimum duration (2 weeks).
†Adjusted mean change relative to baseline.
References: 1. Asthma and Allergy Foundation of America. Rhinitis (nasal allergies). Accessed May 20, 2021. https://www.aafa.org/rhinitis-nasal-allergy-hayfever/ 2. Urdaneta ER, Przygoda PA, Lin CL, et al. Regular use of cetirizine demonstrates consistent relief from symptoms of seasonal allergic rhinitis in children. J Allergy Clin Immunol. 2011;127(suppl 2):AB 202.